ENZO BIOCHEM INC 4 SEC Filings

Filed On	Filing
20 Aug 2025	Form 4: Pully Steven J, Director Returned 239,992 shares to the issuer
20 Aug 2025	Form 4: Radoff Bradley Louis, Director Returned 4,963,779 shares to the issuer
20 Aug 2025	Form 4: Eckert Patricia, Chief Financial Officer Returned 28,328 shares to the issuer · Disposed of 275,000 Stock Option (to acquire shares of Common Stock) (Disposition to Issuer)
20 Aug 2025	Form 4: Couchman Jonathan, Director Returned 605,134 shares to the issuer
20 Aug 2025	Form 4: Cannon Kara, Director Returned 404,802 shares to the issuer · Disposed of 630,400 Stock Option (to acquire shares of Common Stock) (Disposition to Issuer)
17 Jan 2025	Form 4: Pully Steven J, Director Received 142,897 shares as a grant or award
17 Jan 2025	Form 4: Radoff Bradley Louis, Director Received 142,897 shares as a grant or award
17 Jan 2025	Form 4: Couchman Jonathan, Director Received 142,897 shares as a grant or award
25 Jul 2024	Form 4: Eckert Patricia, Chief Financial Officer Granted 100,000 Stock Option (to acquire shares of Common Stock)
24 Jul 2024	Form 4: Cannon Kara, Director Gave up 70,885 shares to cover exercise price or tax ($82.9K)
24 May 2024	Form 4: Cannon Kara, Director Granted 200,000 Stock Option (to acquire shares of Common Stock)
27 Feb 2024	Form 4: Cannon Kara, Director Received 10,640 shares by exercise or conversion · Gave up 5,823 shares to cover exercise price or tax · Received 150,000 shares as a grant or award
27 Feb 2024	Form 4: Eckert Patricia, Chief Financial Officer Granted 75,000 Stock Option (to acquire shares of Common Stock)
02 Feb 2024	Form 4: Radoff Bradley Louis, Director Received 79,365 shares as a grant or award
02 Feb 2024	Form 4: Pully Steven J, Director Received 79,365 shares as a grant or award
02 Feb 2024	Form 4: Tagliaferri Mary, Director Received 79,365 shares as a grant or award
15 Dec 2023	Form 4: Pully Steven J, Director Received 17,730 shares as a grant or award
05 Sep 2023	Form 4: Cannon Kara, Chief Operating Officer Received 345,080 shares as a grant or award · Gave up 63,700 shares to cover exercise price or tax ($98.1K)
31 May 2023	Form 4: Eckert Patricia, Interim CFO Granted 25,000 Stock Option (to acquire Common Stock)
13 Feb 2023	Form 4: Wolf James G., 10% owner until 2/13/2023 Bought 5,000 shares ($6.45K) · Bought 10,000 shares ($12.9K) · Disposed of 324 Long Call Option (right to buy) (Open Market Sale) ($61.6) · 2 more

Comments